Mikhail V. Makarov

1.4k total citations
42 papers, 886 citations indexed

About

Mikhail V. Makarov is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Mikhail V. Makarov has authored 42 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 14 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Mikhail V. Makarov's work include Synthesis and biological activity (10 papers), Organophosphorus compounds synthesis (10 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Mikhail V. Makarov is often cited by papers focused on Synthesis and biological activity (10 papers), Organophosphorus compounds synthesis (10 papers) and Sirtuins and Resveratrol in Medicine (8 papers). Mikhail V. Makarov collaborates with scholars based in United States, Russia and Germany. Mikhail V. Makarov's co-authors include Marie E. Migaud, Ekaterina Yu. Rybalkina, Samuel A.J. Trammell, Irina L. Odinets, Tatiana V. Timofeeva, Faisal Hayat, Gerd‐Volker Röschenthaler, Carles Cantó, Simona Bártová and Maria Pilar Giner and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Mikhail V. Makarov

42 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail V. Makarov United States 17 319 240 226 223 180 42 886
Faisal Hayat United States 19 288 0.9× 147 0.6× 291 1.3× 517 2.3× 117 0.7× 60 1.2k
Bo Tan China 13 266 0.8× 84 0.3× 126 0.6× 76 0.3× 42 0.2× 28 581
Woan-Ru Shieh United States 11 648 2.0× 38 0.2× 306 1.4× 93 0.4× 49 0.3× 19 967
Simon Wing Fai Mok Macao 21 598 1.9× 26 0.1× 205 0.9× 161 0.7× 42 0.2× 35 1.0k
John B. Feltenberger United States 15 225 0.7× 53 0.2× 54 0.2× 408 1.8× 20 0.1× 23 764
Silvio Aprile Italy 18 422 1.3× 24 0.1× 108 0.5× 549 2.5× 22 0.1× 50 1.0k
Takahiro Hatanaka United States 15 535 1.7× 22 0.1× 220 1.0× 41 0.2× 18 0.1× 23 1.1k
Renqiang Sun China 9 197 0.6× 152 0.6× 31 0.1× 11 0.0× 38 0.2× 17 479
Rajiv Kumar Tonk India 12 381 1.2× 14 0.1× 88 0.4× 179 0.8× 20 0.1× 45 852
Mengmeng Wang China 17 507 1.6× 14 0.1× 99 0.4× 99 0.4× 20 0.1× 51 952

Countries citing papers authored by Mikhail V. Makarov

Since Specialization
Citations

This map shows the geographic impact of Mikhail V. Makarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail V. Makarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail V. Makarov more than expected).

Fields of papers citing papers by Mikhail V. Makarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail V. Makarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail V. Makarov. The network helps show where Mikhail V. Makarov may publish in the future.

Co-authorship network of co-authors of Mikhail V. Makarov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail V. Makarov. A scholar is included among the top collaborators of Mikhail V. Makarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail V. Makarov. Mikhail V. Makarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chellappa, Karthikeyani, Melanie R. McReynolds, Wenyun Lu, et al.. (2022). NAD precursors cycle between host tissues and the gut microbiome. Cell Metabolism. 34(12). 1947–1959.e5. 73 indexed citations
2.
Grevengoed, Trisha J., Samuel A.J. Trammell, Mikhail V. Makarov, et al.. (2021). An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. Journal of Clinical Investigation. 131(6). 22 indexed citations
3.
Giner, Maria Pilar, Stefan Christen, Simona Bártová, et al.. (2021). A Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications. International Journal of Molecular Sciences. 22(19). 10598–10598. 22 indexed citations
4.
Koczor, Christopher A., Joel Andrews, Jennifer Clark, et al.. (2021). Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD+/SIRT6 axis. Cell Reports. 37(5). 109917–109917. 44 indexed citations
5.
Strømland, Øyvind, Juha P. Kallio, Lars J. Sverkeli, et al.. (2021). Author Correction: Discovery of fungal surface NADases predominantly present in pathogenic species. Nature Communications. 12(1). 2004–2004. 2 indexed citations
6.
Li, Jianfeng, Md Ibrahim, Xuemei Zeng, et al.. (2021). NAD+ bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells. NAR Cancer. 3(4). zcab044–zcab044. 18 indexed citations
7.
Strømland, Øyvind, Juha P. Kallio, Lars J. Sverkeli, et al.. (2021). Discovery of fungal surface NADases predominantly present in pathogenic species. Nature Communications. 12(1). 1631–1631. 9 indexed citations
8.
Shats, Igor, Jason G. Williams, Juan Liu, et al.. (2020). Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 31(3). 564–579.e7. 164 indexed citations
9.
Sonavane, Manoj, Faisal Hayat, Mikhail V. Makarov, Marie E. Migaud, & Natalie R. Gassman. (2020). Dihydronicotinamide riboside promotes cell-specific cytotoxicity by tipping the balance between metabolic regulation and oxidative stress. PLoS ONE. 15(11). e0242174–e0242174. 23 indexed citations
10.
Makarov, Mikhail V. & Marie E. Migaud. (2019). Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives. Beilstein Journal of Organic Chemistry. 15. 401–430. 23 indexed citations
11.
Joffraud, Magali, Maria Pilar Giner, Simona Bártová, et al.. (2019). A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor. Molecular Metabolism. 30. 192–202. 100 indexed citations
12.
Makarov, Mikhail V., Ekaterina Yu. Rybalkina, Л. В. Аникина, et al.. (2016). 1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties. Medicinal Chemistry Research. 26(1). 140–152. 14 indexed citations
13.
Makarov, Mikhail V., Ekaterina Yu. Rybalkina, & G.‐V. Röschenthaler. (2014). New 3,5-bis(arylidene)-4-piperidones with bisphosphonate moiety: synthesis and antitumor activity. Russian Chemical Bulletin. 63(5). 1181–1186. 1 indexed citations
14.
Makarov, Mikhail V., Ekaterina Yu. Rybalkina, Victor N. Khrustalev, & Gerd‐Volker Röschenthaler. (2014). Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics. Medicinal Chemistry Research. 24(4). 1753–1762. 9 indexed citations
15.
Makarov, Mikhail V., Ekaterina Yu. Rybalkina, Victor N. Khrustalev, et al.. (2012). Methylenebisphosphonates with Dienone Pharmacophore: Synthesis, Structure, Antitumor and Fluorescent Properties. Archiv der Pharmazie. 345(5). 349–359. 18 indexed citations
16.
Fonari, Alexandr, Mikhail V. Makarov, Иван С. Бушмаринов, et al.. (2011). Experimental and theoretical structural study of (3E,5E)-3,5-bis-(benzylidene)-4-oxopiperidinium mono- and (3E,5E)-3,5-bis-(4-N,N-dialkylammonio)benzylidene)-4-oxopiperidinium trications. Journal of Molecular Structure. 1001(1-3). 68–77. 2 indexed citations
17.
Makarov, Mikhail V., et al.. (2010). Structure–cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones. European Journal of Medicinal Chemistry. 45(12). 5926–5934. 23 indexed citations
18.
Makarov, Mikhail V., Ekaterina Yu. Rybalkina, Gerd‐Volker Röschenthaler, et al.. (2008). Design, cytotoxic and fluorescent properties of novel N-phosphorylalkyl substituted E,E-3,5-bis(arylidene)piperid-4-ones. European Journal of Medicinal Chemistry. 44(5). 2135–2144. 41 indexed citations
19.
Proshin, Alexey N., et al.. (2007). Dimer of 5-methyl-3-isoxazolyl isothiocyanate. Chemistry of Heterocyclic Compounds. 43(11). 1483–1484. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faisal Hayat Breakdown of academic impact, for papers by Bo Tan Breakdown of academic impact, for papers by Woan-Ru Shieh Breakdown of academic impact, for papers by Simon Wing Fai Mok Breakdown of academic impact, for papers by John B. Feltenberger Breakdown of academic impact, for papers by Silvio Aprile Breakdown of academic impact, for papers by Takahiro Hatanaka Breakdown of academic impact, for papers by Renqiang Sun Breakdown of academic impact, for papers by Rajiv Kumar Tonk Breakdown of academic impact, for papers by Mengmeng Wang
Rankless by CCL
2026